β-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes

Della C. David, Lars M. Ittner, Peter Gehrig, Denise Nergenau, Claire Shepherd, Glenda Halliday, Jürgen Götz*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'β-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds